Therapeutic Mammoplasty: A Fusion of Oncological and Aesthetic Breast Surgery (Breast Cancer) (Report) Therapeutic Mammoplasty: A Fusion of Oncological and Aesthetic Breast Surgery (Breast Cancer) (Report)

Therapeutic Mammoplasty: A Fusion of Oncological and Aesthetic Breast Surgery (Breast Cancer) (Report‪)‬

Advances in Oncology, 2010, June, 5, 2

    • £2.99
    • £2.99

Publisher Description

Therapeutic mammoplasty, (the use of cosmetic breast reduction techniques in the oncological treatment of breast cancer) is gaining popularity amongst a growing cohort of 'oncoplastic breast surgeons'. Whilst the oncoplastic movement had focused largely upon the need for good post-mastectomy reconstruction, there is probably a greater requirement to ensure the excellence of cosmetic outcomes in the breast-conserving surgery situation. The only justification for breast conservation over total mastectomy is that of leaving a cosmetically acceptable breast for a patient, with the assumed concomitant reduction in psychological morbidity relative to total mastectomy. However, as we shall explain, the cosmetic outcomes from breast-conserving surgery are often far from excellent, and correction of poor aesthetic outcomes in this group of patients, who have largely had postoperative radiotherapy, is a major challenge. The oncoplastic surgeon must be primarily driven by oncological safety, but it is possible to achieve excellent aesthetics without compromise. However, consideration to both aspects must be given from the outset--if the initial resection is performed poorly, this has a major ongoing effect on any subsequent attempts to correct appearance.

GENRE
Health & Well-Being
RELEASED
2010
1 June
LANGUAGE
EN
English
LENGTH
11
Pages
PUBLISHER
Mediscript Ltd.
SIZE
251.3
KB

More Books Like This

Before Breast Cancer Surgery Before Breast Cancer Surgery
2010
Clinical Breast MRI Clinical Breast MRI
2015

More Books by Advances in Oncology

American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium (Conference Report: Gastrointestinal Cancers) American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium (Conference Report: Gastrointestinal Cancers)
2009
Sutent Satellite Symposium: Held Parallel to the 15th Annual Scientific Meeting of Alexandria Clinical Oncology Department (ACOD) Alexandria, Egypt, 14-16 April 2010: a Report from the Symposium (Conference Report: Renal Cell Carcinoma) (Report) Sutent Satellite Symposium: Held Parallel to the 15th Annual Scientific Meeting of Alexandria Clinical Oncology Department (ACOD) Alexandria, Egypt, 14-16 April 2010: a Report from the Symposium (Conference Report: Renal Cell Carcinoma) (Report)
2010
The Future Is Brite (Feature Article) (Clinical Report) The Future Is Brite (Feature Article) (Clinical Report)
2009
Aromatase Inhibitors and Evolution of the Lipid Profile (Clinical Report) Aromatase Inhibitors and Evolution of the Lipid Profile (Clinical Report)
2009
Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma: A New Treatment Paradigm for Locally Advanced and Metastatic Disease in the Era of Targeted Therapy (Feature Article) (Clinical Report) Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma: A New Treatment Paradigm for Locally Advanced and Metastatic Disease in the Era of Targeted Therapy (Feature Article) (Clinical Report)
2010
91-Month Analysis of the Inter-Group Exemestane Study (IES): Exemestane After Initial Therapy with Tamoxifen in Postmenopausal Women with Early Breast Cancer (Breast Cancer) (Case Study) 91-Month Analysis of the Inter-Group Exemestane Study (IES): Exemestane After Initial Therapy with Tamoxifen in Postmenopausal Women with Early Breast Cancer (Breast Cancer) (Case Study)
2010